Glaukos Corp (NYSE: GKOS) CFO sells 10,000 shares, exercises options under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Glaukos Corp SVP & Chief Financial Officer Alex R. Thurman exercised stock options for 10,000 shares of Common Stock at $38.68 per share and, on the same date, sold 10,000 shares at $155.00 per share in an open-market transaction, all under a Rule 10b5-1 trading plan.
After these transactions, he holds 43,681 shares directly, including 5,230 restricted stock units that have not yet vested or been delivered, and 10,000 stock options with a $38.68 exercise price expiring on October 6, 2026, which vest over four years from the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares ($1,550,000)
Net Sell
3 txns
Insider
Thurman Alex R.
Role
SVP & CHIEF FINANCIAL OFFICER
Sold
10,000 shs ($1.55M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 10,000 | $38.68 | $387K |
| Sale | Common Stock | 10,000 | $155.00 | $1.55M |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,000 shares (Direct);
Common Stock — 53,681 shares (Direct)
Footnotes (1)
- Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Key Figures
Shares sold: 10000 shares
Sale price: $155.0000 per share
Shares acquired via option exercise: 10000 shares
+5 more
8 metrics
Shares sold
10000 shares
Common Stock sold on 2026-07-09 at $155.0000 per share in open-market transaction
Sale price
$155.0000 per share
Price for 10,000 Common Stock shares sold on 2026-07-09
Shares acquired via option exercise
10000 shares
Common Stock acquired on 2026-07-09 through derivative exercise at $38.6800 per share
Option exercise price
$38.6800 per share
Exercise price for Stock Option (Right to Buy) underlying 10,000 Common Stock shares
Shares held after transactions
43681 shares
Direct Common Stock holdings following July 9, 2026 transactions
Unvested restricted stock units
5230 units
Restricted stock units included in reported holdings that have not yet vested or been delivered
Options remaining after exercise
10000 options
Stock Option (Right to Buy) remaining after exercise, expiring 2026-10-06
Rule 10b5-1 plan adoption date
December 15, 2025
Date the CFO adopted the trading plan covering these sales and exercises
Key Terms
Rule 10b5-1 trading plan, restricted stock units, Stock Option (Right to Buy), derivative security
4 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"Includes 5,230 restricted stock units that have not yet vested or been delivered"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of $38.6800 per share"
derivative security financial
"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What transactions did Glaukos (GKOS) CFO Alex R. Thurman report on July 9, 2026?
Alex R. Thurman reported exercising options for 10,000 shares at $38.68 and selling 10,000 Common Stock shares at $155.00. Both the option exercise and the share sale occurred on July 9, 2026 under a pre-arranged Rule 10b5-1 trading plan.
Were the Glaukos (GKOS) CFO’s July 9, 2026 transactions under a Rule 10b5-1 plan?
Yes. Footnotes state that both the sales and the option exercises were effected pursuant to a Rule 10b5-1 trading plan adopted by Alex R. Thurman on December 15, 2025, indicating the trades were pre-arranged rather than discretionary.
What derivative holdings and vesting terms does the Glaukos (GKOS) CFO report?
After the transactions, he reports 10,000 stock options with a $38.68 exercise price expiring on October 6, 2026. A footnote explains these options vest over four years, with 25% on the first anniversary and the rest vesting in equal monthly installments.